Subsidizing IVF treatments, delayed marriages and parenthood decisions, and increase in prevalence of infertility issues are the factors that majorly drive the growth of the IVF market in Germany. In addition, as per National Health Plan (NHP), about 50% of the treatment cost by IVF paid for three cycles is projected to boost growth of the IVF market in Germany. However, stringent government regulations and lack of availability in treatment cycles for IVF are the major restraints that hamper the growth of the market in Germany.
The Germany in vitro fertilization market (IVF) is segmented based on cycle type and end user. Based on cycle type, the market is divided into fresh IVF cycles (non-donor), and thawed IVF cycles (non-donor). Based on end user, the market is classified into fertility clinics, hospitals, surgical centers, and clinical research institutes.
KEY MARKET BENEFITS
- The study provides an in-depth analysis of the Germany in vitro fertilization (IVF) market along with the current trends and future estimations to elucidate the imminent investment pockets.
- The report presents a quantitative analysis of the market from 2018 to 2026 to enable stakeholders to capitalize on the prevailing market opportunities.
- An extensive analysis of the market based on application assists in understanding the trends in the industry.
- The key market players along with their strategies are thoroughly analyzed to understand the competitive outlook of the industry.
KEY MARKET SEGMENTS
Germany In Vitro Fertilization Market
By Cycle Type
o Fresh IVF Cycles (Non-donor)
o Thawed IVF Cycles (Non-donor)
By End User
o Fertility Clinics
o Surgical Centers
o Clinical Research Institutes
List of Companies Profiled:
- Heidelberg University Hospital
- Klinikum Stuttgart
- DRK Kliniken Berlin
- University Medical Center Freiburg
What is the estimated value of the German IVF Market?
What is the growth rate of the German IVF Market?
What is the forecasted size of the German IVF Market?
Who are the key companies in the German IVF Market?
|No. of Pages||49|
|Forecast Period||2018 - 2026|
| Estimated Market Value ( USD ||$ 398 million|
| Forecasted Market Value ( USD ||$ 541 million|
|Compound Annual Growth Rate||3.9%|
|No. of Companies Mentioned||4|
Table of Contents
1.2. Key Benefits For Stakeholders
1.3. Key Market Segments
1.3.1. List of Key Players Profiled In The Report
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools And Models
2.2. Cxo Perspective
4.2. Germany IVF Market By Cycle Type
4.2.1. Fresh IVF Cycles (Non-Donor)
4.2.2. Thawed IVF Cycles (Non-Donor)
4.3. Number of Infertility Clinics, 2018
4.4. Germany IVF Market By End Users
4.4.1. Fertility Clinics
4.4.3. Surgical Centers
4.4.4. Clinical Research Institutes
4.5. Market Drivers
18.104.22.168. Subsidizing IVF Treatments
22.214.171.124. Delayed Marriages And Parenthood Decisions
126.96.36.199. Stringent Government Regulations
188.8.131.52. Lack of Availability In Treatment Cycles For IVF
4.5.3. Regulatory Issues, Legislations, And Authorities
4.5.4. Insurance Reimbursement Scenario
4.6. Company Profiles – Germany
4.6.1. Heidelberg University Hospital
184.108.40.206. Company Overview
4.6.2. Klinikum Stuttgart
220.127.116.11. Company Overview
4.6.3. Drk Kliniken Berlin
18.104.22.168. Company Overview
4.6.4. University Medical Center Freiburg
22.214.171.124. Company Overview
4.6.5. Praxis Fur Fertilitat
126.96.36.199. Company Overview
4.6.6. Vivaneo Deutschland Gmbh
188.8.131.52. Company Overview
Executive SummaryAccording to the report titled, 'Germany In Vitro Fertilization (IVF) Market by Cycle Type and End User: Opportunity Analysis and Industry Forecast, 2019-2026', The Germany IVF market was valued at $398 million in 2018 and is estimated to reach $541 million by 2026, registering a CAGR of 3.9% during the analysis period.
Absence of ability or diminished ability to conceive and bear an offspring is termed as infertility. In vitro fertilization (IVF) is a process that is employed to conceive artificially. The process includes five basic steps such as stimulation, egg retrieval, insemination and fertilization, embryo culture, and embryo transfer. The entire process is performed outside the body and once the embryo is ready, it is implanted in the uterus. In the process fertilization occurs outside the body in a laboratory medium. In vitro fertilization is most often tried when other, less expensive, or invasive fertility techniques have failed.
The major factors that boost the growth of the Germany in vitro fertilization market are subsidizing IVF treatments, delayed marriages & parenting decisions, and rise in number of infertility cases. Furthermore, as per National Health Plan (NHP), about 50% of the treatment cost by IVF paid for three cycles is anticipated to drive the growth of the IVF market in Germany. However, stringent government regulations and lack of availability in treatment cycles for IVF are the major restraints that hinder the growth of the market in Germany. Moreover, surge in adoption of IVF technique in the country is expected to provide remunerative opportunities during the forecast period.
According to cycle type, the fresh IVF cycles acquired the largest Germany in vitro fertilization market share in 2018 owing to increased stability offered by the technique. Moreover, the technique has better outcomes when compared to other techniques which boots the growth of this market. Furthermore, thawed IVF cycles is expected to grow with fastest rate during the forecast period owing to the surge in infertility in the region coupled with the increase in number of IVF clinics.
Based on end user, the fertility clinics in the end user segment generated the highest revenue in 2018. The fertility clinics segment is the largest and the fastest growing segment during the forecast period owing to the presence of large number of fertility clinics.
Key Findings of the Germany In Vitro Fertilization (IVF) Market :
By cycle type, fresh IVF cycles in Germany IVF market accounted for largest share in 2018.
By end user, the fertility clinics segment accounted for three-fourths of the market share in 2018.
By end user, the clinical research institutes segment is anticipated to account for one-sixth share of the market in 2018.
- Heidelberg University Hospital
- Klinikum Stuttgart
- DRK Kliniken Berlin
- University Medical Center Freiburg.
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.